Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 06/29 05:35:16 pm
1559.5 GBp   +3.01%
06/21 INNOVIVA : FULFIL study shows superiority of closed triple combinati..
06/20DJGlaxoSmithKline COPD Triple Combination Study Shows Improved Lung..
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 02:24pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
06/28 GLAXOSMITHKLINE PAKISTAN : Material Information of GlaxoSmithKline Pakistan Limi..
06/21 INNOVIVA : FULFIL study shows superiority of closed triple combination therapy F..
06/20DJGlaxoSmithKline COPD Triple Combination Study Shows Improved Lung Function Vs..
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
06/20 GLAXOSMITHKLINE : FULFIL Study Results Closed Triple EU
06/15 IPM GREAT HR DEBATE 2016 : GlaxoSmithkline meets PABC at finals on 21 June
06/14DJGLAXOSMITHKLINE : Vaccines Unit Chairman to Retire Next Year
06/14 GLAXOSMITHKLINE : Executive Director Change
06/14 GLAXOSMITHKLINE : Glaxo Vaccines Chairman Moncef Slaoui To Step Down In 2017
06/10 GLAXOSMITHKLINE : Glaxo's ViiV Gets Approval To Lower Weight Limit For Dolutegra..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials